AQR Capital Management
QTTB icon

AQR Capital Management’s Q32 Bio QTTB Stock Holding History

AQR Capital Management’s Portfolio QTTB Stock Details QTTB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-26,530
Closed -$39.5K – 3621
2025
Q2 		$39.5K Sell
26,530
-14,772
-36% -$25.2K ﹤0.01% 3252
2025
Q1 		$68.1K Buy
+41,302
New +$111K ﹤0.01% 3064
2022
Q2 		– Sell
-2,243
Closed -$123K – 2316
2022
Q1 		$123K Buy
+2,243
New +$139K ﹤0.01% 2122

Other funds holding QTTB

O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
AVLSA
Atlas Venture Life Science Advisors Cambridge, Massachusetts $790M AUM 223.66% 1-Year Est. Return
CG
Carlyle Group Washington, District of Columbia $10.6B AUM 11.25% 1-Year Est. Return
ACA
Acorn Capital Advisors New York $352M AUM 299.18% 1-Year Est. Return
AVM
Arch Venture Management Chicago, Illinois $677M AUM 322.07% 1-Year Est. Return
MAM
Monaco Asset Management Monaco $542M AUM 54.4% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
P
Pfizer New York $239M AUM 232.47% 1-Year Est. Return
S
Sanofi Paris, France $336M AUM 126.85% 1-Year Est. Return
TOCUITCONY
Trustees of Columbia University in the City of New York New York $891M AUM 17.3% 1-Year Est. Return

AQR Capital Management's QTTB Position: Q3 2025 in Review

AQR Capital Management sold out of Q32 Bio (QTTB) in Q3 2025, closing a stake of 26,530 shares — an estimated $39.5K sold.

AQR Capital Management first reported a position in QTTB in Q1 2022 and held it in 3 quarters. The position peaked at $123K in Q1 2022. 53 funds tracked by Wall St. Rank hold QTTB as of Q3 2025.

  • AQR Capital Management reported no remaining Q32 Bio position as of Q3 2025 after selling out during the quarter.
  • AQR Capital Management sold 26,530 Q32 Bio shares in Q3 2025, an estimated $39.5K.
  • AQR Capital Management first reported a position in Q32 Bio in Q1 2022 and held it in 3 quarters.
  • AQR Capital Management's Q32 Bio position peaked at $123K in Q1 2022.
  • 53 funds tracked by Wall St. Rank held Q32 Bio as of Q3 2025.

Based on AQR Capital Management's 13F filing for Q3 2025, filed 14 Nov 2025.